Workflow
D-Wave Quantum (QBTS) - 2024 Q3 - Quarterly Report

Revenue and Cost of Revenue - Revenue decreased by 0.7million(270.7 million (27%) to 1.9 million for Q3 2024 compared to 2.6millioninQ32023,drivenbya2.6 million in Q3 2023, driven by a 1.1 million decrease in professional service revenue partially offset by a 0.5millionincreaseinQCaaSrevenue[91]Revenueincreasedby0.5 million increase in QCaaS revenue[91] - Revenue increased by 0.7 million (11%) to 6.5millionfortheninemonthsendedSeptember30,2024,drivenbya6.5 million for the nine months ended September 30, 2024, driven by a 1.7 million increase in QCaaS revenue[100] - Cost of revenue decreased by 0.2million(200.2 million (20%) to 0.8 million for Q3 2024 compared to 1.0millioninQ32023,primarilyduetoadecreaseinnoncashstockbasedcompensation[92]Costofrevenuedecreasedby1.0 million in Q3 2023, primarily due to a decrease in non-cash stock-based compensation[92] - Cost of revenue decreased by 0.8 million (24%) to 2.4millionfortheninemonthsendedSeptember30,2024,primarilyduetoreductionsinnoncashstockbasedcompensationandpersonnelcosts[101]NetLossandAccumulatedDeficitNetlossincreasedby2.4 million for the nine months ended September 30, 2024, primarily due to reductions in non-cash stock-based compensation and personnel costs[101] Net Loss and Accumulated Deficit - Net loss increased by 6.6 million (41%) to 22.7millionforQ32024comparedto22.7 million for Q3 2024 compared to 16.1 million in Q3 2023[90] - The company had an accumulated deficit of 540.9millionasofSeptember30,2024,withnetcashoutflowsfromoperatingactivitiesof540.9 million as of September 30, 2024, with net cash outflows from operating activities of 44.7 million for the nine months ended September 30, 2024[111] Research and Development Expenses - Research and development expenses decreased by 0.8million(80.8 million (8%) to 8.7 million for Q3 2024 compared to 9.5millioninQ32023,drivenbydecreasesinstockbasedcompensationandfabricationcosts[93]Researchanddevelopmentexpensesdecreasedby9.5 million in Q3 2023, driven by decreases in stock-based compensation and fabrication costs[93] - Research and development expenses decreased by 4.4 million (15%) to 25.5millionfortheninemonthsendedSeptember30,2024,drivenbylowerstockbasedcompensationandpersonnelcosts[102]GeneralandAdministrativeExpensesGeneralandadministrativeexpensesincreasedby25.5 million for the nine months ended September 30, 2024, driven by lower stock-based compensation and personnel costs[102] General and Administrative Expenses - General and administrative expenses increased by 1.3 million (16%) to 9.3millionforQ32024comparedto9.3 million for Q3 2024 compared to 8.0 million in Q3 2023, primarily due to increases in professional services and credit losses[94] - General and administrative expenses decreased by 4.6million(164.6 million (16%) to 24.3 million for the nine months ended September 30, 2024, primarily due to reductions in professional fees and stock-based compensation[103] Sales and Marketing Expenses - Sales and marketing expenses increased by 1.3million(521.3 million (52%) to 3.8 million for Q3 2024 compared to 2.5millioninQ32023,drivenbyincreasesinpersonnelcostsandstockbasedcompensation[95]Salesandmarketingexpensesincreasedby2.5 million in Q3 2023, driven by increases in personnel costs and stock-based compensation[95] - Sales and marketing expenses increased by 3.4 million (43%) to 11.2millionfortheninemonthsendedSeptember30,2024,drivenbyhigherpersonnelcostsandstockbasedcompensation[104]InterestExpenseandTermLoanInterestexpenseincreasedby11.2 million for the nine months ended September 30, 2024, driven by higher personnel costs and stock-based compensation[104] Interest Expense and Term Loan - Interest expense increased by 0.1 million (14%) to 1.2millionforQ32024comparedto1.2 million for Q3 2024 compared to 1.0 million in Q3 2023, primarily due to the Term Loan[96] - Interest expense increased by 1.7million(911.7 million (91%) to 3.5 million for the nine months ended September 30, 2024, primarily due to the Term Loan[105] - The fair value of the Term Loan increased by 1.6millionforQ32024comparedtoadecreaseof1.6 million for Q3 2024 compared to a decrease of 1.7 million in Q3 2023[97] - The fair value of the Term Loan increased by 0.6millionfortheninemonthsendedSeptember30,2024,comparedtoadecreaseof0.6 million for the nine months ended September 30, 2024, compared to a decrease of 1.4 million in the same period in 2023[106] - Term Loan debt issuance costs decreased by 0.7millionforQ32024comparedtoQ32023,astherewerenoadvancesontheTermLoanduringQ32024[98]OtherIncomeandExpensesGainoninvestmentinmarketableequitysecuritiesincreasedby0.7 million for Q3 2024 compared to Q3 2023, as there were no advances on the Term Loan during Q3 2024[98] Other Income and Expenses - Gain on investment in marketable equity securities increased by 1.5 million for the nine months ended September 30, 2024, due to an acquisition of an investee[108] - Other income (expense), net increased by 1.8million(53651.8 million (5365%) to 1.8 million for the nine months ended September 30, 2024, driven by foreign exchange gains and higher interest income[110] Cash Flow and Liquidity - Net cash used in operating activities for the nine months ended September 30, 2024 was 44.7million,adecreaseof44.7 million, a decrease of 1.3 million from 45.9millionin2023[115]NetcashusedininvestingactivitiesfortheninemonthsendedSeptember30,2024was45.9 million in 2023[115] - Net cash used in investing activities for the nine months ended September 30, 2024 was 2.2 million, an increase of 2.0millionfrom2.0 million from 0.2 million in 2023[116] - Net cash provided by financing activities for the nine months ended September 30, 2024 was 34.9million,adecreaseof34.9 million, a decrease of 57.5 million from 92.4millionin2023[118]ProceedsfromtheissuanceofcommonstockpursuanttotheATMAgreementwere92.4 million in 2023[118] - Proceeds from the issuance of common stock pursuant to the ATM Agreement were 20.7 million for the nine months ended September 30, 2024[118] - The company's liquidity condition raises substantial doubt about its ability to continue as a going concern for one year from the issuance of the financial statements[113] - The decrease in noncash items was primarily due to a 5.6milliondecreaseinstockbasedcompensationanda5.6 million decrease in stock-based compensation and a 3.1 million decrease in non-cash interest expense[115] - The increase in cash used in investing activities was primarily due to a 1.0millionpurchaseofconvertiblenotesanda1.0 million purchase of convertible notes and a 1.0 million increase in property and equipment purchases[116] - The decrease in cash provided by financing activities was primarily due to a 29.2milliondecreaseinproceedsfromtheissuanceofcommonstockanda29.2 million decrease in proceeds from the issuance of common stock and a 29.0 million decrease in debt financing proceeds[118] - The company may need to obtain additional capital through debt or equity issuance if sufficient capital is not obtained from existing agreements[113] - The company's operating cash flows are significantly affected by research and development, sales and marketing, and general and administrative activities[115] QCaaS Revenue Expectations - The company expects QCaaS revenue as a percentage of total revenue to increase due to more QCaaS agreements driven by professional services engagements and direct Leap cloud service access[84]